Parkinson’s Disease

107 results.

December 14, 2021 A year — and a quarter century — in review

As 2021 comes to a close, so too does Van Andel Institute’s celebration of our 25th anniversary. The Institute’s story began with a vision: to…

November 15, 2021 Graduate student spotlight: Investigating the links between the immune system and Parkinson’s disease

Throughout the year, we highlight Van Andel Institute Graduate School’s doctoral students. This month, we’re featuring Alysa Kasen, a Ph.D. student in the lab of Dr.…

September 16, 2021 Explainer: What is the gut microbiome?

Our microbiomes take the phrase “trust your gut” to a whole new level. The gut microbiome is a rich population of bacteria, fungi, viruses and…

April 27, 2021 A genetic revolution in Parkinson’s: A Q&A with Dr. Ted Dawson

Each year during our Grand Challenges in Parkinson’s Disease symposium, Van Andel Institute presents the Jay Van Andel Award for Outstanding Achievement in…

April 1, 2021 GBA and LRRK2: What two key genes mean for Parkinson’s

For many people who develop Parkinson’s disease, some of the risk may be written in their genes. But so too may be answers that lead…

March 19, 2021 New uses for existing medications provide hope for Parkinson’s disease breakthroughs

Drug repurposing program seeks to find treatments that slow or stop Parkinson’s progression and serve as a roadmap for similar initiatives in other diseases Could…

January 15, 2021 Graduate student spotlight: Exploring genetic risk in Parkinson’s

Throughout the year, we highlight Van Andel Institute Graduate School’s doctoral students. This month, we’re featuring Alix Booms, a student in the lab of Dr.…